| UniProt ID | CDC7_HUMAN | |
|---|---|---|
| UniProt AC | O00311 | |
| Protein Name | Cell division cycle 7-related protein kinase | |
| Gene Name | CDC7 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 574 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | Seems to phosphorylate critical substrates that regulate the G1/S phase transition and/or DNA replication. Can phosphorylates MCM2 and MCM3.. | |
| Protein Sequence | MEASLGIQMDEPMAFSPQRDRFQAEGSLKKNEQNFKLAGVKKDIEKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKSHIITGNKIPLSGPVPKELDQQSTTKASVKRPYTNAQIQIKQGKDGKEGSVGLSVQRSVFGERNFNIHSSISHESPAVKLMKQSKTVDVLSRKLATKKKAISTKVMNSAVMRKTASSCPASLTCDCYATDKVCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHASHQPAISEKTDHKASCLVQTPPGQYSGNSFKKGDSNSCEHCFDEYNTNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMSL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 4 | Phosphorylation | ----MEASLGIQMDE ----CCCCCCCCCCC | 17.52 | 26074081 | |
| 16 | Phosphorylation | MDEPMAFSPQRDRFQ CCCCCCCCCCHHHHH | 15.58 | 17192257 | |
| 27 | Phosphorylation | DRFQAEGSLKKNEQN HHHHHHCCCHHCHHC | 28.64 | 25159151 | |
| 29 | Ubiquitination | FQAEGSLKKNEQNFK HHHHCCCHHCHHCCE | 56.07 | - | |
| 30 | Ubiquitination | QAEGSLKKNEQNFKL HHHCCCHHCHHCCEE | 71.64 | - | |
| 36 | Sumoylation | KKNEQNFKLAGVKKD HHCHHCCEECCHHHH | 45.00 | - | |
| 36 | Sumoylation | KKNEQNFKLAGVKKD HHCHHCCEECCHHHH | 45.00 | - | |
| 36 | Ubiquitination | KKNEQNFKLAGVKKD HHCHHCCEECCHHHH | 45.00 | - | |
| 48 | Phosphorylation | KKDIEKLYEAVPQLS HHHHHHHHHHHHHHH | 16.95 | 27642862 | |
| 59 | Sumoylation | PQLSNVFKIEDKIGE HHHHCCEEEECCCCC | 40.69 | - | |
| 59 | Sumoylation | PQLSNVFKIEDKIGE HHHHCCEEEECCCCC | 40.69 | - | |
| 59 | Ubiquitination | PQLSNVFKIEDKIGE HHHHCCEEEECCCCC | 40.69 | - | |
| 90 | Ubiquitination | PEEKIALKHLIPTSH CHHHHHHHHHCCCCC | 27.61 | - | |
| 179 | Ubiquitination | GIVHRDVKPSNFLYN CCCCCCCCCHHHCCC | 47.20 | - | |
| 179 | Sumoylation | GIVHRDVKPSNFLYN CCCCCCCCCHHHCCC | 47.20 | - | |
| 179 | Sumoylation | GIVHRDVKPSNFLYN CCCCCCCCCHHHCCC | 47.20 | - | |
| 181 | Phosphorylation | VHRDVKPSNFLYNRR CCCCCCCHHHCCCCC | 34.20 | 19664994 | |
| 191 | Ubiquitination | LYNRRLKKYALVDFG CCCCCCCEEEEECCC | 40.11 | - | |
| 192 | Phosphorylation | YNRRLKKYALVDFGL CCCCCCEEEEECCCC | 11.99 | 29496907 | |
| 207 | Ubiquitination | AQGTHDTKIELLKFV CCCCCHHHHHHHHHH | 39.99 | - | |
| 212 | Ubiquitination | DTKIELLKFVQSEAQ HHHHHHHHHHHHHHH | 56.99 | 2190698 | |
| 216 | Phosphorylation | ELLKFVQSEAQQERC HHHHHHHHHHHHHHH | 29.60 | - | |
| 227 | Ubiquitination | QERCSQNKSHIITGN HHHHHCCCCCEECCC | 35.46 | - | |
| 235 | Sumoylation | SHIITGNKIPLSGPV CCEECCCCCCCCCCC | 47.23 | - | |
| 235 | Sumoylation | SHIITGNKIPLSGPV CCEECCCCCCCCCCC | 47.23 | - | |
| 235 | Ubiquitination | SHIITGNKIPLSGPV CCEECCCCCCCCCCC | 47.23 | - | |
| 239 | Phosphorylation | TGNKIPLSGPVPKEL CCCCCCCCCCCCCCC | 35.38 | 23312004 | |
| 244 | Sumoylation | PLSGPVPKELDQQST CCCCCCCCCCCCCCC | 71.75 | - | |
| 244 | Sumoylation | PLSGPVPKELDQQST CCCCCCCCCCCCCCC | 71.75 | - | |
| 244 | Ubiquitination | PLSGPVPKELDQQST CCCCCCCCCCCCCCC | 71.75 | - | |
| 253 | Ubiquitination | LDQQSTTKASVKRPY CCCCCCCCCCCCCCC | 38.46 | - | |
| 255 | Phosphorylation | QQSTTKASVKRPYTN CCCCCCCCCCCCCCC | 29.72 | - | |
| 257 | Ubiquitination | STTKASVKRPYTNAQ CCCCCCCCCCCCCEE | 45.20 | - | |
| 260 | Phosphorylation | KASVKRPYTNAQIQI CCCCCCCCCCEEEEE | 19.36 | 25690035 | |
| 261 | Phosphorylation | ASVKRPYTNAQIQIK CCCCCCCCCEEEEEE | 27.10 | 25690035 | |
| 268 | Sumoylation | TNAQIQIKQGKDGKE CCEEEEEEECCCCCC | 36.30 | - | |
| 268 | Sumoylation | TNAQIQIKQGKDGKE CCEEEEEEECCCCCC | 36.30 | 28112733 | |
| 268 | Ubiquitination | TNAQIQIKQGKDGKE CCEEEEEEECCCCCC | 36.30 | - | |
| 274 | Ubiquitination | IKQGKDGKEGSVGLS EEECCCCCCCCEEEE | 69.87 | - | |
| 274 | Sumoylation | IKQGKDGKEGSVGLS EEECCCCCCCCEEEE | 69.87 | - | |
| 274 | Sumoylation | IKQGKDGKEGSVGLS EEECCCCCCCCEEEE | 69.87 | - | |
| 277 | Phosphorylation | GKDGKEGSVGLSVQR CCCCCCCCEEEEEEE | 17.69 | 20873877 | |
| 281 | Phosphorylation | KEGSVGLSVQRSVFG CCCCEEEEEEEHHHC | 15.41 | 20873877 | |
| 285 | Phosphorylation | VGLSVQRSVFGERNF EEEEEEEHHHCCCCE | 12.52 | - | |
| 296 | Phosphorylation | ERNFNIHSSISHESP CCCEECCCCCCCCCH | 26.10 | 20873877 | |
| 297 | Phosphorylation | RNFNIHSSISHESPA CCEECCCCCCCCCHH | 17.59 | 20873877 | |
| 299 | Phosphorylation | FNIHSSISHESPAVK EECCCCCCCCCHHHH | 24.13 | 21712546 | |
| 302 | Phosphorylation | HSSISHESPAVKLMK CCCCCCCCHHHHHHH | 16.85 | 25159151 | |
| 306 | Ubiquitination | SHESPAVKLMKQSKT CCCCHHHHHHHCCCH | 44.99 | - | |
| 312 | Ubiquitination | VKLMKQSKTVDVLSR HHHHHCCCHHHHHHH | 50.50 | - | |
| 318 | Phosphorylation | SKTVDVLSRKLATKK CCHHHHHHHHHHHHH | 27.50 | - | |
| 331 | Sumoylation | KKKAISTKVMNSAVM HHHHHHHHHHCHHHH | 32.47 | - | |
| 331 | Sumoylation | KKKAISTKVMNSAVM HHHHHHHHHHCHHHH | 32.47 | - | |
| 331 | Acetylation | KKKAISTKVMNSAVM HHHHHHHHHHCHHHH | 32.47 | 30587557 | |
| 331 | Ubiquitination | KKKAISTKVMNSAVM HHHHHHHHHHCHHHH | 32.47 | - | |
| 340 | Ubiquitination | MNSAVMRKTASSCPA HCHHHHHHCCCCCCC | 30.28 | - | |
| 348 | Phosphorylation | TASSCPASLTCDCYA CCCCCCCCEECCEEE | 14.89 | 19690332 | |
| 356 | Phosphorylation | LTCDCYATDKVCSIC EECCEEECCCHHHHH | 15.18 | 19690332 | |
| 358 | Ubiquitination | CDCYATDKVCSICLS CCEEECCCHHHHHHH | 40.56 | - | |
| 361 | Phosphorylation | YATDKVCSICLSRRQ EECCCHHHHHHHCCC | 21.23 | 30631047 | |
| 365 | Phosphorylation | KVCSICLSRRQQVAP CHHHHHHHCCCCCCC | 22.47 | 30631047 | |
| 376 | Phosphorylation | QVAPRAGTPGFRAPE CCCCCCCCCCCCCHH | 21.18 | 10846177 | |
| 386 | Phosphorylation | FRAPEVLTKCPNQTT CCCHHHHHCCCCCCC | 35.46 | - | |
| 406 | Phosphorylation | SAGVIFLSLLSGRYP HHHHHHHHHHHCCCC | 19.26 | 28355574 | |
| 415 | Phosphorylation | LSGRYPFYKASDDLT HHCCCCCEECCHHHH | 10.92 | - | |
| 441 | Ubiquitination | RETIQAAKTFGKSIL HHHHHHHHHHCCHHH | 47.61 | - | |
| 445 | Acetylation | QAAKTFGKSILCSKE HHHHHHCCHHHCCCC | 30.08 | 26051181 | |
| 445 | Ubiquitination | QAAKTFGKSILCSKE HHHHHHCCHHHCCCC | 30.08 | - | |
| 451 | Ubiquitination | GKSILCSKEVPAQDL CCHHHCCCCCCHHHH | 62.83 | - | |
| 451 | Acetylation | GKSILCSKEVPAQDL CCHHHCCCCCCHHHH | 62.83 | 23749302 | |
| 472 | Phosphorylation | LRGMDSSTPKLTSDI HCCCCCCCCCCCCCC | 28.52 | 28985074 | |
| 474 | Ubiquitination | GMDSSTPKLTSDIQG CCCCCCCCCCCCCCC | 65.57 | - | |
| 484 | Phosphorylation | SDIQGHASHQPAISE CCCCCCCCCCCCCCC | 19.58 | - | |
| 490 | Phosphorylation | ASHQPAISEKTDHKA CCCCCCCCCCCCCCC | 34.84 | 25159151 | |
| 492 | Ubiquitination | HQPAISEKTDHKASC CCCCCCCCCCCCCEE | 53.08 | - | |
| 493 | Phosphorylation | QPAISEKTDHKASCL CCCCCCCCCCCCEEE | 39.01 | 28555341 | |
| 498 | Phosphorylation | EKTDHKASCLVQTPP CCCCCCCEEEEECCC | 16.88 | - | |
| 503 | Phosphorylation | KASCLVQTPPGQYSG CCEEEEECCCCCCCC | 24.79 | 25159151 | |
| 508 | Phosphorylation | VQTPPGQYSGNSFKK EECCCCCCCCCCCCC | 25.18 | 26074081 | |
| 509 | Phosphorylation | QTPPGQYSGNSFKKG ECCCCCCCCCCCCCC | 24.50 | 25159151 | |
| 512 | Phosphorylation | PGQYSGNSFKKGDSN CCCCCCCCCCCCCCC | 41.80 | 28985074 | |
| 556 | Phosphorylation | LLDLNPASRITAEEA HHCCCHHHCCCHHHH | 26.02 | - | |
| 559 | Phosphorylation | LNPASRITAEEALLH CCHHHCCCHHHHHHC | 27.23 | - | |
| 570 | Ubiquitination | ALLHPFFKDMSL--- HHHCHHHHCCCC--- | 53.56 | - | |
| 573 | Phosphorylation | HPFFKDMSL------ CHHHHCCCC------ | 40.85 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 216 | S | Phosphorylation | Kinase | CDC7 | O00311 | PSP |
| 239 | S | Phosphorylation | Kinase | CDC7 | O00311 | PSP |
| 277 | S | Phosphorylation | Kinase | CDC7 | O00311 | PSP |
| 285 | S | Phosphorylation | Kinase | CDC7 | O00311 | PSP |
| 296 | S | Phosphorylation | Kinase | CDC7 | O00311 | PSP |
| 297 | S | Phosphorylation | Kinase | CDC7 | O00311 | PSP |
| 318 | S | Phosphorylation | Kinase | CDC7 | O00311 | PSP |
| 376 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 376 | T | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CDC7_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CDC7_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; TYR-508 AND SER-509,AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16 AND SER-27, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-503, AND MASSSPECTROMETRY. | |